Inhibition of de novo ceramide synthesis by Sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes.
Velagapudi S, Karsai G, Karsai M, Mohammed SA, Montecucco F, Liberale L, Lee H, Carbone F, Francesco Adami G, Yang K, Crucet M, Stein S, Paneni F, Lapikova-Bryhinska T, Jang HD, Kraler S, Vdovenko D, Arnold Züllig R, Camici GG, Kim HS, Laaksonen R, Gerber PA, Hornemann T, Akhmedov A, Lüscher TF.
Velagapudi S, et al. Among authors: laaksonen r.
Cardiovasc Res. 2024 May 13:cvae100. doi: 10.1093/cvr/cvae100. Online ahead of print.
Cardiovasc Res. 2024.
PMID: 38739545